HealthEquity raises FY23 EPS view to $1.26-$1.35 from $1.23-$1.32

Consensus $1.27. Raises FY23 revenue view to $850M-$860M from $834M-$844M, consensus $839.5M. The company said, "For the fiscal year ending January 31, 2023, management expects revenue of $850 million to $860 million. Its outlook for net loss is between $34 million and $27 million, resulting in net loss of $0.40 to $0.32 per diluted share. Its outlook for non-GAAP net income, calculated using the method described below, is between $106 million and $114 million, resulting in non-GAAP net income per diluted share of $1.26 to $1.35 (based on an estimated 84 million diluted weighted-average shares outstanding). Management expects Adjusted EBITDA of $261 million to $271 million."